So basically they've paintented an entire approach to the treatment of KD. Smart move. The must be confident that this protein is a key to treatment and have locked themselves into royalties if they or anybody else develops a treatment using this approach. Suddenly PromarkerD has become a when lot more valuable!
Ann: US patent for identifying drugs for abnormal kidney function, page-3
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
66.5¢ |
Change
-0.030(4.32%) |
Mkt cap ! $87.11M | |||
| Open | High | Low | Value | Volume |
| 68.5¢ | 68.5¢ | 65.5¢ | $74.33K | 111.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 29294 | 65.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 67.0¢ | 21598 | 5 |
View Market Depth
| Last trade - 13.25pm 04/10/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |